Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| How molecular advances may improve the diagnosis and management of PTCL patients. | Front Oncol | 2023 | 37427095 | PubTator, text mining | PubMed |
| ZNF143 facilitates the growth and migration of glioma cells by regulating KPNA2-mediated Hippo signalling. | Sci Rep | 2023 | 37423952 | PubTator, text mining | PubMed |
| Long non‑coding RNA PTCSC3 suppresses triple‑negative breast cancer by downregulating long non‑coding RNA MIR100HG. | Oncol Lett | 2023 | 37415630 | PubTator, text mining | PubMed |
| Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma. | Nat Commun | 2023 | 37414763 | PubTator, text mining | PubMed |
| Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity. | Cell Death Dis | 2023 | 37414748 | PubTator, text mining | PubMed |
| Inducible Protein Degradation as a Strategy to Identify Phosphoprotein Phosphatase 6 Substrates in RAS-Mutant Colorectal Cancer Cells. | Mol Cell Proteomics | 2023 | 37392812 | PubTator, text mining | PubMed |
| Somatic gain-of-function mutations in BUD13 promote oncogenesis by disrupting Fbw7 function. | J Exp Med | 2023 | 37382881 | PubTator, text mining | PubMed |
| miR-497 Regulates LATS1 through the PPARG Pathway to Participate in Fatty Acid Synthesis in Bovine Mammary Epithelial Cells. | Genes (Basel) | 2023 | 37372404 | PubTator, text mining | PubMed |
| The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy? | Cancers (Basel) | 2023 | 37370771 | PubTator, text mining | PubMed |
| In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer Patients. | Cancers (Basel) | 2023 | 37370765 | PubTator, text mining | PubMed |
| Mechanical Properties of Glioblastoma: Perspectives for YAP/TAZ Signaling Pathway and Beyond. | Diseases | 2023 | 37366874 | PubTator, text mining | PubMed |
| Novel insights into mutual regulation between N6-methyladenosine modification and LncRNAs in tumors. | Cancer Cell Int | 2023 | 37365581 | PubTator, text mining | PubMed |
| A comprehensive review of stroke-related signaling pathways and treatment in western medicine and traditional Chinese medicine. | Front Neurosci | 2023 | 37351420 | PubTator, text mining | PubMed |
| Integrating physicomechanical and biological strategies for BTE: biomaterials-induced osteogenic differentiation of MSCs. | Theranostics | 2023 | 37351163 | PubTator, text mining | PubMed |
| O‑GlcNAcylation mediates endometrial cancer progression by regulating the Hippo‑YAP pathway. | Int J Oncol | 2023 | 37350405 | PubTator, text mining | PubMed |
| Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth. | J Clin Invest | 2023 | 37347559 | PubTator, text mining | PubMed |
| Targeting the Divergent Roles of STK3 Inhibits Breast Cancer Cell Growth and Opposes Doxorubicin-Induced Cardiotoxicity In Vitro. | Cancers (Basel) | 2023 | 37345153 | PubTator, text mining | PubMed |
| Whole-Genome Doubling as a source of cancer: how, when, where, and why? | Front Cell Dev Biol | 2023 | 37342233 | PubTator, text mining | PubMed |
| Molecular signaling in cancer stem cells of tongue squamous cell carcinoma: Therapeutic implications and challenges. | World J Stem Cells | 2023 | 37342225 | PubTator, text mining | PubMed |
| Significance of liquid-liquid phase separation (LLPS)-related genes in breast cancer: a multi-omics analysis. | Aging (Albany NY) | 2023 | 37338518 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=19